Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease: A Post Hoc Analysis of 2 Randomized Clinical Trials

IMPORTANCE: An investigation of the treatment effect of lifitegrast ophthalmic solution, 5.0%, in different subgroups by severity of dry eye disease (DED) seems warranted. OBJECTIVE: To explore the heterogeneity across different subgroups of DED and identify which participants were most likely to ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Holland, Edward J., Jackson, Mitchell A., Donnenfeld, Eric, Piccolo, Rebecca, Cohen, Alisa, Barabino, Stefano, Rolando, Maurizio, Figueiredo, Francisco C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498931/
https://www.ncbi.nlm.nih.gov/pubmed/34617974
http://dx.doi.org/10.1001/jamaophthalmol.2021.3943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498931/
https://www.ncbi.nlm.nih.gov/pubmed/34617974
http://dx.doi.org/10.1001/jamaophthalmol.2021.3943

Ejemplares similares